New recovery protocol aims to get stomach cancer patients home sooner

NCT ID NCT03997162

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This phase II trial tests an enhanced recovery after surgery (ERAS) protocol in 52 people with stage 0 to IIIC gastric cancer who are having surgery. The goal is to see if this approach can reduce pain, nausea, and hospital stays while improving quality of life. Participants receive standard care plus questionnaires to track their recovery and well-being.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
enhanced recovery after surgery protocol (standard care plus quality-of-life assessments and questionnaires)
What this could lead to
If successful, this could establish a standard recovery plan that helps gastric cancer patients feel better faster after surgery and spend fewer days in the hospital.
What could go wrong
This is a small, single-center trial with only 52 participants, so results may not apply to all patients. The protocol is based on standard care, so major breakthroughs are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLINICAL STAGE 0 GASTRIC CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.